SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001485003-18-000054
Filing Date
2018-05-04
Accepted
2018-05-04 16:13:36
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 ebio-formsx32018piperesale.htm S-3 302096
2 EXHIBIT 5.1 ex51ebio-hoganopinionmarch.htm EX-5.1 15263
3 EXHIBIT 10.2 exhibit102ebio-spaamendmen.htm EX-10.2 28657
4 EXHIBIT 23.1 ex231eyconsentforforms-3x0.htm EX-23.1 2383
5 ebioexhibit51opinionm_image1.jpg GRAPHIC 28105
6 ebioforms32018piperes_image1.jpg GRAPHIC 22023
  Complete submission text file 0001485003-18-000054.txt   418571
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-224682 | Film No.: 18808074
SIC: 2834 Pharmaceutical Preparations